These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7533113)
21. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy. Shindo M; Hamada K; Koya S; Arai K; Sokawa Y; Okuno T Hepatology; 1996 Nov; 24(5):1018-23. PubMed ID: 8903369 [TBL] [Abstract][Full Text] [Related]
22. Nucleotide sequence diversity of hypervariable region 1 of hepatitis C virus in Japanese hemophiliacs with chronic hepatitis C and patients with chronic posttransfusion hepatitis C. Toyoda H; Fukuda Y; Koyama Y; Nakano I; Kinoshita M; Hadama T; Takamatsu J; Hayakawa T Blood; 1996 Aug; 88(4):1488-93. PubMed ID: 8695870 [TBL] [Abstract][Full Text] [Related]
23. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. González-Peralta RP; Qian K; She JY; Davis GL; Ohno T; Mizokami M; Lau JY J Med Virol; 1996 Jul; 49(3):242-7. PubMed ID: 8818972 [TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of hepatitis C virus quasispecies. Enomoto N; Sato C J Viral Hepat; 1995; 2(6):267-72. PubMed ID: 8732171 [TBL] [Abstract][Full Text] [Related]
25. [Clinical studies on the detection of hepatitis C virus genome in the serum and the liver]. Hige S Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1382-98. PubMed ID: 7535730 [TBL] [Abstract][Full Text] [Related]
26. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy. Kurosaki M; Enomoto N; Murakami T; Sakuma I; Asahina Y; Yamamoto C; Ikeda T; Tozuka S; Izumi N; Marumo F; Sato C Hepatology; 1997 Mar; 25(3):750-3. PubMed ID: 9049230 [TBL] [Abstract][Full Text] [Related]
27. Mode of HCV infection examined by polymorphism of hypervariable region-1 in cases of acute hepatitis C after accidental exposure to blood-borne pathogens. Takeda T; Tatsumi N; Nakayama Y; Yasuda T; Nishiguchi S; Seki S J Med Virol; 2005 Jan; 75(1):35-41. PubMed ID: 15543585 [TBL] [Abstract][Full Text] [Related]
28. Changes in hepatitis C virus quasispecies and density populations in patients before and after interferon therapy. Nagasaka A; Hige S; Tsunematsu I; Yoshida J; Sasaki Y; Matsushima T; Asaka M J Med Virol; 1996 Nov; 50(3):214-20. PubMed ID: 8923285 [TBL] [Abstract][Full Text] [Related]
29. Antiviral effect of human recombinant interleukin-12 in patients infected with hepatitis C virus. Lee JH; Teuber G; von Wagner M; Roth WK; Zeuzem S J Med Virol; 2000 Mar; 60(3):264-8. PubMed ID: 10630957 [TBL] [Abstract][Full Text] [Related]
30. Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C. Kurosaki M; Enomoto N; Marumo F; Sato C Virology; 1994 Nov; 205(1):161-9. PubMed ID: 7975211 [TBL] [Abstract][Full Text] [Related]
31. Differences in hypervariable region 1 quasispecies of hepatitis C virus between human serum and peripheral blood mononuclear cells. Fujii K; Hino K; Okazaki M; Okuda M; Kondoh S; Okita K Biochem Biophys Res Commun; 1996 Aug; 225(3):771-6. PubMed ID: 8780688 [TBL] [Abstract][Full Text] [Related]
32. [Clinical implications of HCV quasispecies heterogeneity in patients with hepatitis C]. Tang X; Qian K; Lau JY Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):173-5. PubMed ID: 11436653 [TBL] [Abstract][Full Text] [Related]
33. Fraction-specific populations of the hypervariable region of the hepatitis C virus in a patient with cryoglobulinemia. Kurosaki M; Enomoto N; Nouchi T; Sakuma I; Marumo F; Sato C J Med Virol; 1995 Aug; 46(4):403-8. PubMed ID: 7595420 [TBL] [Abstract][Full Text] [Related]
34. Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy. Sandres K; Dubois M; Pasquier C; Payen JL; Alric L; Duffaut M; Vinel JP; Pascal JP; Puel J; Izopet J J Virol; 2000 Jan; 74(2):661-8. PubMed ID: 10623727 [TBL] [Abstract][Full Text] [Related]
35. [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response]. Berg T; Kaul T; Naumann U; Wiedenmann B; Hopf U Z Gastroenterol; 2000 Nov; 38(11):881-6. PubMed ID: 11132533 [TBL] [Abstract][Full Text] [Related]
36. Single-strand conformation polymorphism for analysis of genomic variability of hepatitis C virus nonstructure 5A region. Ding J; Yang J; Tian M Chin Med J (Engl); 1998 Dec; 111(12):1114-7. PubMed ID: 11263377 [TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection. Leone F; Zylberberg H; Squadrito G; Le Guen B; Berthelot P; Pol S; Brechot C J Hepatol; 1998 Nov; 29(5):689-94. PubMed ID: 9833904 [TBL] [Abstract][Full Text] [Related]
38. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Zeuzem S; Lee JH; Roth WK Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228 [TBL] [Abstract][Full Text] [Related]
39. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Shindo M; Di Bisceglie AM; Cheung L; Shih JW; Cristiano K; Feinstone SM; Hoofnagle JH Ann Intern Med; 1991 Nov; 115(9):700-4. PubMed ID: 1656828 [TBL] [Abstract][Full Text] [Related]
40. [Structural analysis of the PKR-binding region of HCV 1b samples from patients with chronic hepatitis C and the correlation with IFN-sensitivity]. Gervain J; Czibula A; Simon J; Kalmár T Orv Hetil; 2003 Jun; 144(24):1179-84. PubMed ID: 12866147 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]